View More View Less
  • 1 University of Szeged Department of Neurology P.O. Box 427 H-6701 Szeged Hungary
  • | 2 Semmelweis u. 6 H-6725 Szeged Hungary
  • | 3 University of Szeged Department of Pharmacology and Pharmacotherapy P.O. Box 427 H-6701 Szeged Hungary
  • | 4 Neurology Research Group of the Hungarian Academy of Sciences and University of Szeged P.O. Box 427 H-6701 Szeged Hungary
  • | 5 Hungarian Academy of Sciences Division of Cardiovascular Pharmacology P.O. Box 427 H-6701 Szeged Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

Depression, which is associated with an increased incidence of vascular events, frequently occurs following stroke. Selective serotonin reuptake inhibitory drugs (SSRIs) as antidepressants, are well tolerated, and also seem to be effective in post-stroke depression. The aim of this study was to investigate the effects of the SSRIs citalopram and fluoxetine, on the corticocerebral blood flow (cCBF) in rabbits with unilateral carotid occlusion induced cerebral ischemia. The cCBF was measured by the hydrogen clearance technique. After determination of the mean baseline cCBF, the effects of individual doses (0.1, 0.3 and 1 mg/kg) of citalopram or fluoxetine on the cCBF were investigated. Following the induction of an impaired cCBF, the changes in cCBF after drug treatments in this condition were likewise measured. The mean arterial blood pressure (MABP) and the heart rate (HR) from the electrocardiogram (ECG) were also determined. Neither citalopram nor fluoxetine influenced the cCBF in the control group. Fluoxetine improved the cCBF only very slightly in the ischemic animals. In contrast, all the doses of citalopram exerted pronounced and dose-dependent cCBF-increasing effects in the animals with unilateral carotid occlusion (maximal mean ΔCBF: 10, 16 and 27 ml/min/100 g tissue). The HR was decreased in both groups. Only citalopram treatment led to a slight MABP-decreasing effect. Besides enhancement of the serotonergic transmission in the brain, the cCBF-increasing effect of citalopram under ischemic conditions may be of benefit in post-stroke and vascular depression.

  • Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M: ’Vascular depression’ hypothesis. Arch. Gen. Psychiatry 54, 915–922 (1997)

    Charlson M. , '’Vascular depression’ hypothesis ' (1997 ) 54 Arch. Gen. Psychiatry : 915 -922.

    • Search Google Scholar
  • Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M: Clinically defined vascular depression. Am. J. Psychiatry 154, 562–565 (1997)

    Charlson M. , 'Clinically defined vascular depression ' (1997 ) 154 Am. J. Psychiatry : 562 -565.

    • Search Google Scholar
  • Andersen G, Vestergaard K, Lauritzen L: Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25, 1099–1104 (1994)

    Lauritzen L. , 'Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram ' (1994 ) 25 Stroke : 1099 -1104.

    • Search Google Scholar
  • Aukland K, Bower BF, Berliner RW: Measurement of local blood flow with hydrogen gas. Circ. Res. 14, 164–187 (1964)

    Berliner R.W. , 'Measurement of local blood flow with hydrogen gas ' (1964 ) 14 Circ. Res. : 164 -187.

    • Search Google Scholar
  • Bak S, Tsiropoulos I, Kjærsgaard JO, Andersen M, Mellerup E, Hallas J, Garcia Rodríguez LA, Christensen K, Gaist D: Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 33, 465–473 (2002)

    Gaist D. , 'Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study ' (2002 ) 33 Stroke : 465 -473.

    • Search Google Scholar
  • Bonne O, Krausz Y: Pathophysiological significance of cerebral perfusion abnormalities in major depression-trait or state marker. Eur. Neuropsychopharmacol. 7, 225–233 (1997)

    Krausz Y. , 'Pathophysiological significance of cerebral perfusion abnormalities in major depression-trait or state marker ' (1997 ) 7 Eur. Neuropsychopharmacol. : 225 -233.

    • Search Google Scholar
  • Bonne O, Krausz Y, Aharon Y, Gelfin Y, Chisin R, Lerer B: Clinical doses of fluoxetine and cerebral blood flow in healthy volunteers. Psychopharmacology (Berl.) 143, 24–28 (1999)

    Lerer B. , 'Clinical doses of fluoxetine and cerebral blood flow in healthy volunteers ' (1999 ) 143 Psychopharmacology (Berl.) : 24 -28.

    • Search Google Scholar
  • Boyeson MG, Harmon RL, Jones JL: Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury. Am. J. Phys. Med. Rehabil. 73, 76–83 (1994)

    Jones J.L. , 'Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury ' (1994 ) 73 Am. J. Phys. Med. Rehabil. : 76 -83.

    • Search Google Scholar
  • Brust P, Friedrich A, Krizbai IA, Bergmann R, Roux F, Ganapathy V, Johannsen B: Functional expression of the serotonin transporter in immortalized rat brain microvessel endothelial cells. J. Neurochem. 74, 1241–1248 (2000)

    Johannsen B. , 'Functional expression of the serotonin transporter in immortalized rat brain microvessel endothelial cells ' (2000 ) 74 J. Neurochem. : 1241 -1248.

    • Search Google Scholar
  • Csete K, Papp JG: Effects of moxonidine on corticocerebral blood flow under normal and ischemic conditions in conscious rabbits. J. Cardiovasc. Pharmacol. 35, 417–421 (2000)

    Papp J.G. , 'Effects of moxonidine on corticocerebral blood flow under normal and ischemic conditions in conscious rabbits ' (2000 ) 35 J. Cardiovasc. Pharmacol. : 417 -421.

    • Search Google Scholar
  • Folstein M, Maiberger R, McHugh P: Mood disturbance as specific complication in stroke. J. Neurol. Neurosurg. Psychiatry 40, 1018–1020 (1977)

    McHugh P. , 'Mood disturbance as specific complication in stroke ' (1977 ) 40 J. Neurol. Neurosurg. Psychiatry : 1018 -1020.

    • Search Google Scholar
  • Gainotti G, Azzoni A, Marra C: Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br. J. Psychiatry 175, 163–167 (1999)

    Marra C. , 'Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression ' (1999 ) 175 Br. J. Psychiatry : 163 -167.

    • Search Google Scholar
  • Gelfin Y, Gorfine M, Lerer B: Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. Am. J. Psychiatry 155, 290–292 (1998)

    Lerer B. , 'Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers ' (1998 ) 155 Am. J. Psychiatry : 290 -292.

    • Search Google Scholar
  • House A, Dennis M, Warlow C, Hawton K, Molyneux A: Mood disorders after stroke and their relation to lesion location. A CT scan study. Brain 113, 1113–1129 (1990)

    Molyneux A. , 'Mood disorders after stroke and their relation to lesion location. A CT scan study ' (1990 ) 113 Brain : 1113 -1129.

    • Search Google Scholar
  • Kitazono T, Ibayashi S, Nagao T, Kagiyama T, Kitayama J, Fujishima M: Role of tyrosine kinase in serotonin-induced constriction of the basilar artery in vivo. Stroke 29, 494–498 (1998)

    Fujishima M. , 'Role of tyrosine kinase in serotonin-induced constriction of the basilar artery in vivo ' (1998 ) 29 Stroke : 494 -498.

    • Search Google Scholar
  • Lesser IM, Mena I, Boone KB, Miller BL, Mehringer CM, Wohl M: Reduction of cerebral blood flow in older depressed patients. Arch. Gen. Psychiatry 51, 677–686 (1994)

    Wohl M. , 'Reduction of cerebral blood flow in older depressed patients ' (1994 ) 51 Arch. Gen. Psychiatry : 677 -686.

    • Search Google Scholar
  • Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR: Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 11, 297–300 (1984)

    Price T.R. , 'Nortriptyline treatment of post-stroke depression: a double-blind study ' (1984 ) 11 Lancet : 297 -300.

    • Search Google Scholar
  • Lou HC, Edvinsson L: Influence of serotinin and norepinephrine on flow capacity/pressure characteristics of feline isolated cerebral arteries. Stroke 17, 91–94 (1986)

    Edvinsson L. , 'Influence of serotinin and norepinephrine on flow capacity/pressure characteristics of feline isolated cerebral arteries ' (1986 ) 17 Stroke : 91 -94.

    • Search Google Scholar
  • Mast BT, Vedrody S: Poststroke depression: a biopsychosocial approach. Curr. Psychiatry Rep. 8, 25–33 (2006)

    Vedrody S. , 'Poststroke depression: a biopsychosocial approach ' (2006 ) 8 Curr. Psychiatry Rep. : 25 -33.

    • Search Google Scholar
  • McDonald DA, Potter JM: The distribution of blood to the brain. J. Physiol. 114, 356–364 (1951)

    Potter J.M. , 'The distribution of blood to the brain ' (1951 ) 114 J. Physiol. : 356 -364.

  • Mirzoian RS, Topchian AV, Ganshina TS, Kostochka LM: Tropoxin and cerebrovascular effects of serotonin. Eksp. Klin. Farmakol. 63, 21–23 (2000)

    Kostochka L.M. , 'Tropoxin and cerebrovascular effects of serotonin ' (2000 ) 63 Eksp. Klin. Farmakol. : 21 -23.

    • Search Google Scholar
  • Monnier M, Gangloff H (1961): Atlas for stereotaxic brain research on the conscious rabbit. In: Rabbit brain research (Vol 1), Elsevier Publishing, Amsterdam, pp. 1–76

    Gangloff H. , '', in Rabbit brain research (Vol 1) , (1961 ) -.

  • Nakata N, Kato H, Kogure K: Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil. Brain Res. 590, 48–52 (1992)

    Kogure K. , 'Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil ' (1992 ) 590 Brain Res. : 48 -52.

    • Search Google Scholar
  • Neu P, Schlattman P, Schilling A, Hartmann A: Cerebrovascular reactivity in major depression: a pilot study. Psychosom. Med. 66, 6–8 (2004)

    Hartmann A. , 'Cerebrovascular reactivity in major depression: a pilot study ' (2004 ) 66 Psychosom. Med. : 6 -8.

    • Search Google Scholar
  • Nobler MS, Olvet KR, Sackeim HA: Effects of medications on cerebral blood flow in late-life depression. Curr. Psychiatry Rep. 4, 51–58 (2002)

    Sackeim H.A. , 'Effects of medications on cerebral blood flow in late-life depression ' (2002 ) 4 Curr. Psychiatry Rep. : 51 -58.

    • Search Google Scholar
  • Pacher P, Ungvari Z, Kecskemeti V, Furst S: Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants. Curr. Med. Chem. 5, 381–390 (1998)

    Furst S. , 'Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants ' (1998 ) 5 Curr. Med. Chem. : 381 -390.

    • Search Google Scholar
  • Robinson RG: Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol. Psychiatry 54, 376–387 (2003)

    Robinson R.G. , 'Poststroke depression: prevalence, diagnosis, treatment, and disease progression ' (2003 ) 54 Biol. Psychiatry : 376 -387.

    • Search Google Scholar
  • Robinson RG, Bolduc PL, Price TR: Two-year longitudinal study of poststroke mood disorders: diagnosis and outcome at one and two years. Stroke 18, 837–843 (1987)

    Price T.R. , 'Two-year longitudinal study of poststroke mood disorders: diagnosis and outcome at one and two years ' (1987 ) 18 Stroke : 837 -843.

    • Search Google Scholar
  • Robinson RG, Kubos KL, Starr LB, Rao K, Price TR: Mood disorders in stroke patients. Importance of location of lesion. Brain 107, 81–93 (1984)

    Price T.R. , 'Mood disorders in stroke patients. Importance of location of lesion ' (1984 ) 107 Brain : 81 -93.

    • Search Google Scholar
  • Sackeim HA, Prohovnik I, Moeller JR, Brown RP, Apter S, Prudic J, Devanand DP, Mukherjee S: Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. Arch. Gen. Psychiatry 47, 60–70 (1990)

    Mukherjee S. , 'Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest ' (1990 ) 47 Arch. Gen. Psychiatry : 60 -70.

    • Search Google Scholar
  • Terstappen GC, Pellacani A, Aldegheri L, Graziani F, Carignani C, Pula G, Virginio C: The antidepressant fluoxetine blocks the human small conductance calcium-activated potassium channels SK1, SK2 and SK3. Neurosci. Lett. 346, 85–88 (2003)

    Virginio C. , 'The antidepressant fluoxetine blocks the human small conductance calcium-activated potassium channels SK1, SK2 and SK3 ' (2003 ) 346 Neurosci. Lett. : 85 -88.

    • Search Google Scholar
  • Tiemeier H, Bakker SLM, Hofman A, Koudstaal PJ, Breteler MMB: Cerebral haemodynamics and depression in the elderly. J. Neurol. Neurosurg. Psychiatry 73, 34–39 (2002)

    Breteler M.M.B. , 'Cerebral haemodynamics and depression in the elderly ' (2002 ) 73 J. Neurol. Neurosurg. Psychiatry : 34 -39.

    • Search Google Scholar
  • Turner-Stokes L, Hassan N: Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 1: Diagnosis, frequency and impact. Clin. Rehabil. 16, 231–247 (2002)

    Hassan N. , 'Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 1: Diagnosis, frequency and impact ' (2002 ) 16 Clin. Rehabil. : 231 -247.

    • Search Google Scholar
  • Turner-Stokes L, Hassan N: Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives. Clin. Rehabil. 16, 248–260 (2002)

    Hassan N. , 'Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives ' (2002 ) 16 Clin. Rehabil. : 248 -260.

    • Search Google Scholar
  • Ungvari Z, Pacher P, Kecskeméti V, Koller A: Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca 2+ channel opener. Stroke 30, 1949–1954 (1999)

    Koller A. , 'Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca2+ channel opener ' (1999 ) 30 Stroke : 1949 -1954.

    • Search Google Scholar
  • Van de Meent H, Geurts AC, Van Limbeek J: Pharmacologic treatment of poststroke depression: a systematic review of the literature. Top Stroke Rehabil. 10, 73–92 (2003)

    Limbeek J. , 'Pharmacologic treatment of poststroke depression: a systematic review of the literature ' (2003 ) 10 Top Stroke Rehabil. : 73 -92.

    • Search Google Scholar
  • Vanhoutte PM: Vascular effects of serotonin and ischemia. J. Cardiovasc. Pharmacol. 16(Suppl 3), S15–S19 (1990)

    Vanhoutte P.M. , 'Vascular effects of serotonin and ischemia ' (1990 ) 16 J. Cardiovasc. Pharmacol. : S15 -S19.

    • Search Google Scholar
  • Wegener G, Volke V, Harvey BH, Rosenberg R: Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res. 959, 128–134 (2003)

    Rosenberg R. , 'Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity ' (2003 ) 959 Brain Res. : 128 -134.

    • Search Google Scholar
  • Whyte EM, Mulsant BH: Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol. Psychiatry 52, 253–264 (2002)

    Mulsant B.H. , 'Post stroke depression: epidemiology, pathophysiology, and biological treatment ' (2002 ) 52 Biol. Psychiatry : 253 -264.

    • Search Google Scholar
  • Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M: Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 31, 1829–1832 (2000)

    Barat M. , 'Fluoxetine in early poststroke depression: a double-blind placebo-controlled study ' (2000 ) 31 Stroke : 1829 -1832.

    • Search Google Scholar

The author instruction is available in PDF.

Please, download the file from HERE

Senior editors

Editor(s)-in-Chief: Rosivall, László

Honorary Editor(s)-in-Chief): Monos, Emil

Managing Editor(s): Bartha, Jenő; Berhidi, Anna

Co-editor(s): Koller, Ákos; Lénárd, László; Szénási, Gábor

Assistant Editor(s): G. Dörnyei (Budapest), Zs. Miklós (Budapest), Gy. Nádasy (Budapest)

Hungarian Editorial Board

    1. Benedek, György (Szeged)
    1. Benyó, Zoltán (Budapest)
    1. Boros, Mihály (Szeged)
    1. Chernoch, László (Debrecen)
    1. Détári, László (Budapest)
    1. Hamar, János (Budapest)
    1. Hantos, Zoltán (Szeged)
    1. Hunyady, László (Budapest)
    1. Imre, Sándor (Debrecen)
    1. Jancsó, Gábor (Szeged)
    1. Karádi, Zoltán (Pécs)
    1. Kovács, László (Debrecen)
    1. Palkovits, Miklós (Budapest)
    1. Papp, Gyula (Szeged)
    1. Pavlik, Gábor (Budapest)
    1. Spät, András (Budapest)
    1. Szabó, Gyula (Szeged)
    1. Szelényi, Zoltán (Pécs)
    1. Szolcsányi, János (Pécs)
    1. Szollár, Lajos (Budapest)
    1. Szücs, Géza (Debrecen)
    1. Telegdy, Gyula (Szeged)
    1. Toldi, József (Szeged)
    1. Tósaki, Árpád (Debrecen)

International Editorial Board

    1. R. Bauer (Jena)
    1. W. Benjelloun (Rabat)
    1. A. W. Cowley Jr. (Milwaukee)
    1. D. Djuric (Belgrade)
    1. C. Fry (London)
    1. S. Greenwald (London)
    1. O. Hänninen (Kuopio)
    1. H. G. Hinghofer-Szalkay (Graz)
    1. Th. Kenner (Graz)
    1. Gy. Kunos (Richmond)
    1. M. Mahmoudian (Tehran)
    1. T. Mano (Seki, Gifu)
    1. G. Navar (New Orleans)
    1. H. Nishino (Nagoya)
    1. O. Petersen (Liverpool)
    1. U. Pohl (Münich)
    1. R. S. Reneman (Maastricht)
    1. A. Romanovsky (Phoenix)
    1. G. M. Rubanyi (Richmond)
    1. T. Sakata (Oita)
    1. A. Siddiqui (Karachi)
    1. Cs. Szabo (Beverly)
    1. E. Vicaut (Paris)
    1. N. Westerhof (Amsterdam)
    1. L. F. Zhang (Xi'an)

Editorial Office:
Akadémiai Kiadó Zrt.
Prielle Kornélia u. 21–35, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Physiologica Hungarica
Semmelweis University, Faculty of Medicine Institute of Pathophysiology
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: aph@semmelweis-univ.hu

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • EMBASE/Excerpta Medica
  • Global Health
  • Index Copernicus
  • Index Medicus
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index Expanded
  • SCOPUS

 

Acta Physiologica Hungarica
Language English
Size  
Year of
Foundation
1950
Publication
Programme
changed title
Volumes
per Year
 
Issues
per Year
 
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0231-424X (Print)
ISSN 1588-2683 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Aug 2021 28 0 0
Sep 2021 0 0 0
Oct 2021 7 0 0
Nov 2021 6 0 0
Dec 2021 7 0 0
Jan 2022 1 0 0
Feb 2022 0 0 0